My last blood work showed that the lambda light chain numbers had climbed again, the ratio between kappa and lambda is dropping and the Beta-2-Microglobulin, Serum has continued to rise. These markers are going in the wrong direction and it is upsetting.
Being back in treatment has been a difficult transition for me. My whole mindset and emotional state are trying to adjust to this new reality of multiple myeloma back on the attack. I was never completely comfortable while I was in remission, knowing that it was temporary. However, I had hoped that "temporary" would last a long time and I was able to keep a relatively positive attitude. Now, I am beset with fear and uncertainty about the chances of dominating this disease again.The one positive note in all of this is my oncologist said the amount of myeloma activity is still small, so I am hopeful that Velcade will be able to overpower it and beat it back into submission.
When one is battling multiple myeloma or any aggressive disease, a fierce attitude is probably a good thing to have. To that end, I think I should be calling Velcade by its more ferocious sounding name: Bortezimib.
Though she be but little, she is fierce!
William Shakespeare
My Lab Work
| Component | Standard Range | 11/29/12 | 1/3/13 | 1/31/13 |
|---|---|---|---|---|
| Kappa Lght Chn, Free | 3.3-8.0 mg/L | 9.15 | 7.83 | 8.25 |
| Lambda Lght Chn, Free | 5.7-26.3 mg/L | 42.64 | 51.37 | 62.64 |
| Kappa/Lambda,Free | 0.26-1.65 ratio | 0.21 | 0.15 | 0.13 |
| Component | Standard Range | 4/15/10 | 7/5/12 | 10/26/12 | 1/31/13 |
|---|---|---|---|---|---|
| Beta-2-Microglobulin, Serum | < OR=2.51 | 2.25 | 2.60 | 2.81 | 3.03 |
